Search research articles
Contact Us
Filters
Showing results (121-130 of 126) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 126 results.
Biochemistry
|
April 9, 1999
Circular permutation of the granulocyte colony-stimulating factor receptor agonist domain of myelopoietin
C A McWherter, Y Feng, L L Zurfluh, et al.
Cancer Immunology, Immunotherapy : CII
|
April 19, 2021
Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma: a retrospective multicenter DeCOG study
H M Stege, M Haist, S Schultheis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 19, 2006
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG
D Schadendorf, S Ugurel, B Schuler-Thurner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 13, 2015
Radiosensitization by BRAF inhibitor therapy-mechanism and frequency of toxicity in melanoma patients
M Hecht, L Zimmer, C Loquai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 23, 2026
IO102-IO103 immune-modulatory cancer vaccine and pembrolizumab in melanoma
J C Hassel, A Arance, M S Carlino, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
September 12, 2013
[Phlebology in German departments of dermatology. An analysis on behalf of the German Society of Phlebology]
S Reich-Schupke, J Alm, P Altmeyer, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 126) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 126 results.
Biochemistry
|
April 9, 1999
Circular permutation of the granulocyte colony-stimulating factor receptor agonist domain of myelopoietin
C A McWherter, Y Feng, L L Zurfluh, et al.
Cancer Immunology, Immunotherapy : CII
|
April 19, 2021
Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma: a retrospective multicenter DeCOG study
H M Stege, M Haist, S Schultheis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 19, 2006
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG
D Schadendorf, S Ugurel, B Schuler-Thurner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 13, 2015
Radiosensitization by BRAF inhibitor therapy-mechanism and frequency of toxicity in melanoma patients
M Hecht, L Zimmer, C Loquai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 23, 2026
IO102-IO103 immune-modulatory cancer vaccine and pembrolizumab in melanoma
J C Hassel, A Arance, M S Carlino, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
September 12, 2013
[Phlebology in German departments of dermatology. An analysis on behalf of the German Society of Phlebology]
S Reich-Schupke, J Alm, P Altmeyer, et al.
Page
of 13